Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04012749 · ClinicalTrials.gov registry record · NA
UC Health Care Planning Study
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 8,707
- Enrollment target
NCT04012749: Completed NA study, sponsored by University of California, Los Angeles.
NCT04012749 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 8,707 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (521% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04012749, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 8,707 participants
- Enrollment target
Study Summary
Using a cluster randomized design at the clinic level, this project will implement and test three real-world, scalable advance care planning interventions among primary care clinics across three University of California health systems. Seriously ill patients identified using data from the electronic health record will receive (1) an advance directive with targeted messaging, (2) intervention 1 plus prompting to engage with the Prepare For Your Care website, or (3) intervention 2 plus engagement from a clinic-based facilitator. A Research cohort of patients will provide complete surveys at baseline, 12 and 24 months. The main outcomes are advance directive completion among the population cohort and goal concordant care among the Research cohort at 12 months.
Primary Outcome
Proportion of patients that have advance care planning documentation (enduring advance directive, POLST or out-of-hospital DNR form in the electronic health record) at 12 months (or death) compared to baseline. Baseline date defined as the clinic intervention start date. Intention to treat analysis will use logistic regression models to account for patients clustered within clinics including covariates of patient age, gender, race/ethnicity, serious illness category, clinic baseline advance dire
Interventions
- BEHAVIORAL Advance directive
- BEHAVIORAL Prepare
- BEHAVIORAL Facilitator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,707 participants |
| Start Date | 2019-10-25 |
| Est. Completion | 2024-09-15 |
| Phase | NA |
What the finished NCT04012749 record still lists
NCT04012749 is an interventional study that assigns participants to a tested intervention. Its 8,707 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (521% higher).
The record links to 0 conditions, and to 3 interventions - of which Advance directive is the first listed.
NCT04012749 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04012749 about?
NCT04012749 is a clinical study titled "UC Health Care Planning Study". Using a cluster randomized design at the clinic level, this project will implement and test three real-world, scalable advance care planning interventions among primary care clinics across three University of California health systems. Seriously ill patients identified using data from the electronic...
What is the current status of trial NCT04012749?
This trial is currently completed. It is a NA study. The enrollment target is 8,707 participants. The study started on 2019-10-25. Estimated completion is 2024-09-15.
What interventions are being tested in trial NCT04012749?
The interventions under investigation include: Advance directive (BEHAVIORAL), Prepare (BEHAVIORAL), Facilitator (BEHAVIORAL).
Who is sponsoring clinical trial NCT04012749?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04012749's enrollment target sits among peer trials
8,707 18th of 2000 higher than 1,983 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06058234 · 8,680 participants
Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study
- NCT05336877 · 8,744 participants
Aveir VR Coverage With Evidence Development Post-Approval Study
- NCT06098079 · 8,600 participants · Phase 4
Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)
- NCT05612347 · 8,946 participants · NA
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI